Let’s Recap – 3 Takeaways from My Talk with Select Health’s Chief Pharmacy Benefits Officer
Learn how utilizing the right technology and member engagement strategies can help patients and plans struggling with high pharmacy costs
Uncategorized
What to Make of the GLP-1 Coverage and Cost Landscape
How payers are handling the rise of GLP-1s? Cost and clinical transparency can support whatever strategy a plan takes.
What to Make of the GLP-1 Coverage and Cost Landscape Read More »
RxSS Member Support – Savings and Satisfaction in One Call or Click
RxSS member support comes from pharmacy technicians who go all out to find affordable prescriptions and deliver peace of mind.
RxSS Member Support – Savings and Satisfaction in One Call or Click Read More »
How Payers Can Leverage the Cash Pharmacy and Discount Card Trend
Consumers have more choices for purchasing prescriptions without insurance. How can plans capture what they’re missing?
How Payers Can Leverage the Cash Pharmacy and Discount Card Trend Read More »
More Patients Turning to Cash Pharmacies and Discount Cards
Patients and plans both benefit from better medication access, affordability and adherence. Cash pharmacies and discount cards—in tandem with the pharmacy benefit—can help improve all three.
More Patients Turning to Cash Pharmacies and Discount Cards Read More »
Prescription Delivery and Digital Pharmacies Consumer Adoption
The pandemic brought an uptick in prescription deliveries, yet they still lag behind most other online purchases. Here’s why that is bound to change.
Prescription Delivery and Digital Pharmacies Consumer Adoption Read More »
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus Read More »
Humira Biosimilars and other Biologic Alternatives
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
Humira Biosimilars and other Biologic Alternatives Read More »
Drug Cost Comparison Tools and Healthcare Cost Transparency Come to Life
Seemingly since the beginning of time, consumers have rarely known what a doctor visit, medical procedure or medication will cost until it’s time to pay. Fortunately, things are starting to change.
Drug Cost Comparison Tools and Healthcare Cost Transparency Come to Life Read More »
Why Are the Most Important Rx Decision-makers Still in the Dark?
The only people who can write prescriptions typically have no idea what patients will pay at the pharmacy. It’s time to solve this problem.
Why Are the Most Important Rx Decision-makers Still in the Dark? Read More »
